The Valley Desk

Clinical trial reportClinical lung cancerPublished

Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical lung cancer
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Organophosphorus Compounds; Pyrimidines; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Drug Resistance, Neoplasm; Mutation; Adult; Aged; Aged, 80 and over
PubMed ID
40582920
Added to directory
Source checked

Report a correction or request removal